Findings on Hypersensitivity Reported by Investigators at Brigham and Women's Hospital (Hypersensitivity Reactions To Taxanes: a Comprehensive and Systematic Review of the Efficacy and Safety of Desensitization).

Patients tolerated well RDD and breakthrough reactions (BTR) occurred in 32.2% of paclitaxel-treated patients and in 20.6% of docetaxel treated patients. Boston, State:Massachusetts, United States, North and Central America, Antineoplastics, Cycloparaffins, Diterpenes, Docetaxel Therapy, Drugs and Therapies, Health and Medicine, Hydrocarbons, Hypersensitivity, Immune System Diseases and Conditions, Immunology, Mitotic Inhibitors, Organic Chemicals, Paclitaxel Therapy, Pharmaceuticals, Taxoids, Terpenes Keywords: Boston; State:Massachusetts; United States; North and Central America; Antineoplastics; Cycloparaffins; Diterpenes; Docetaxel Therapy; Drugs and Therapies; Health and Medicine; Hydrocarbons; Hypersensitivity; Immune System Diseases and Conditions; Immunology; Mitotic Inhibitors; Organic Chemicals; Paclitaxel Therapy; Pharmaceuticals; Taxoids; Terpenes EN Boston State:Massachusetts United States North and Central America Antineoplastics Cycloparaffins Diterpenes Docetaxel Therapy Drugs and Therapies Health and Medicine Hydrocarbons Hypersensitivity Immune System Diseases and Conditions Immunology Mitotic Inhibitors Organic Chemicals Paclitaxel Therapy Pharmaceuticals Taxoids Terpenes 670 670 1 09/19/23 20230922 NES 230922 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Immune System Diseases and Conditions - Hypersensitivity is the subject of a report. [Extracted from the article]